EN
Bone cancer is a rare tumour, and it is precisely its rarity that makes the beginning hardest: not every doctor meets such cases often, and people frequently go through several consulting rooms before they hear a clear diagnosis. By the time treatment abroad comes up there are usually images and pain that nobody could explain for a long time. The German approach starts by naming the type of tumour precisely — everything else depends on that.
What people arrive with
Primary bone tumours are not one disease. Osteosarcoma, Ewing sarcoma and chondrosarcoma behave differently, occur at different ages and require different treatment. So the phrase “bone cancer” says almost nothing about the plan by itself: first it has to be established which tumour this is, where it lies and whether the neighbouring tissue is involved. The stage is described in general terms — from early and confined to advanced — and it too influences the choice of approach.
How the diagnosis is confirmed
The assessment usually begins with an X-ray — the first to show a change in the bone. Then come MRI, which sees the tumour and its borders in the soft tissue well, and CT. To establish whether there are deposits in other bones, scintigraphy or PET is used, along with blood tests. But the decisive word belongs to the biopsy.
In bone tumours the biopsy is entrusted to the very team that will later operate — and that is not a formality. A badly chosen entry point can later make limb-sparing surgery harder. Examination of the tissue, including its molecular features, establishes exactly which tumour this is and what can act on it. In effect, controlled treatment begins with a properly taken biopsy.
Which approaches are used
Treatment is most often combined, and the order of the steps matters. For a number of tumours (osteosarcoma and Ewing sarcoma, for example) chemotherapy comes first, to shrink the tumour and act on possible microscopic deposits, then the operation, and drug treatment continues afterwards. In other forms, such as chondrosarcoma, surgery plays the main role.
The main direction of modern surgery is to save the limb. In most cases limb-sparing surgery is possible: the affected section of bone is removed and replaced with a prosthesis or a bone graft, and the function of the limb is restored. Amputation today is a last resort, used only when nothing else will do. Reconstructive techniques deserve separate mention: they can restore support and movement even after a large fragment of bone has been removed.
Radiotherapy is used selectively — it matters particularly in Ewing sarcoma and where an operation is difficult. Which methods to use and in what order is decided by a board: oncologist, orthopaedic surgeon, radiation oncologist and pathologist look at the case together.
A second opinion
Because these tumours are rare, a second opinion here is not a luxury but a sensible step. A German sarcoma specialist reviews the images and the histology and says whether they agree with the diagnosis and the plan. It is often the experience of a centre that manages such cases regularly which determines whether the limb can be saved and the treatment arranged in the right order.
This material is for information only and does not replace a consultation with a doctor. Whether treatment is possible, what it will involve and what it will achieve can be determined only after an examination at the clinic in person.